Search results
Canadian Sikhs thought they were safe to protest against India. Then one of them was gunned down
The Economist· 4 days agoSingh, who had served on the temple’s executive committee for over 15 years and was revered by the...
Darryl Thomas DuBose - The Andalusia Star-News
The Andalusia Star-News· 4 days agoDarryl was born on Oct. 13, 1940 in Sanford, Alabama and lived there until he graduated from Straughn High School and joined the U.S. Navy. After...
Oxford teacher donates bone marrow to help a man with leukemia in Italy
WBRC Fox 6 Birmingham· 6 days agoThis week, an east Alabama educator is helping a man living 5,000 miles away get a second chance at...
Ayala Pharmaceuticals (NASDAQ:ADXS) Coverage Initiated by Analysts at StockNews.com
ETF DAILY NEWS· 6 days agoStockNews.com assumed coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research report report published on Wednesday morning. The firm issued a sell rating on the ...
LADENBURG THALM/SH SH Downgrades Coeptis Therapeutics (NASDAQ:COEP) to Hold
ETF DAILY NEWS· 3 days agoCoeptis Therapeutics (NASDAQ:COEP – Get Free Report) was downgraded by equities research analysts at LADENBURG THALM/SH SH from a “strong-buy” rating to a “hold” rating in a research note issued ...
With iOnctura and Yellowstone, Syncona adds two cancer biotechs to growing portfolio
FierceBiotech· 5 days agoSyncona has added two up-and-coming cancer companies to its portfolio, ensuring the biotechs are armed with a combined total of over $100 million in series A and B funds. The London-based investment ...
Coeptis Therapeutics (NASDAQ:COEP) Downgraded to Hold at LADENBURG THALM/SH SH
ETF DAILY NEWS· 3 days agoLADENBURG THALM/SH SH cut shares of Coeptis Therapeutics (NASDAQ:COEP – Free Report) from a strong-buy rating to a hold rating in a research report sent to investors on Tuesday morning, Zacks.com ...
Coeptis Therapeutics (NASDAQ:COEP) Lowered to Hold at LADENBURG THALM/SH SH
ETF DAILY NEWS· 3 days agoLADENBURG THALM/SH SH lowered shares of Coeptis Therapeutics (NASDAQ:COEP – Free Report) from a strong-buy rating to a hold rating in a report published on Tuesday, Zacks.com reports. Coeptis ...
Cullinan Therapeutics (NASDAQ:CGEM) Shares Gap Down to $18.88
ETF DAILY NEWS· 7 days agoCullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) shares gapped down prior to trading on Monday . Cullinan Therapeutics shares last traded at $18.56, with a volume of 60,955 shares ...
